May 17, 2010 – When patients present with chest pain or other high-risk symptoms of heart problems, doctors increasingly rely on nuclear imaging and computed tomography (CT) to find evidence of heart disease. Results of these procedures can help guide life-saving prevention and treatment options.

May 17, 2010 – The first clinical cases using an irrigated ablation catheter were recently completed in the European Union, following recent CE Mark approval. The Thermocool SF irrigated ablation catheter is designed for use by electrophysiologists in treating cardiac arrhythmias.

May 17, 2010 – The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the creation of the Accreditation for Cardiovascular Excellence (ACE) organization.

May 17, 2010 – New STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the number of paroxysmal atrial fibrillation (AF) patients reporting AF symptoms declined by 80 percent after treatment with the Arctic Front Cardiac CryoAblation Catheter System.

May 14, 2010 – New evidence demonstrates key shock-reduction programming strategies significantly reduced implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) shocks from 17 to 28 percent. The study also identified programming and patient characteristics that increased the risk of shocks.

May 14, 2010 — A partnership to develop cardiovascular genomic diagnostic testing devices has been signed between GE Healthcare and CardioDx.

May 14, 2010 – Research published in the April issue of The Journal of Simulation in Healthcare demonstrates the potential for high-fidelity simulations in assessing the performance of interventional cardiologists.


A quick look at the current statistics sends an alarming message: The state of cardiovascular health in the United States is abysmal. With diabetes and obesity on the rise, we as physicians need to take the lead to help the U.S. population manage its increasing risk for developing cardiovascular-related disease.

May 13, 2010 – An easy-to-wear, single-use, continuous ambulatory cardiac rhythm monitor yields high-quality diagnostic information, while providing greater patient comfort and improved compliance. The U.S. Food and Drug Administration (FDA) recently cleared the Zio Patch.

May 13, 2010 – The U.S. Food and Drug Administration (FDA) has cleared a small pacemaker with integrated, wireless, remote monitoring capabilities. The Evia pacemaker is 20 percent smaller than previously released Biotronik pacemakers.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now